汉族马凡综合征(MFS)患者FBN1基因两种新发突变分析
收稿日期: 2009-07-09
修回日期: 2009-10-12
网络出版日期: 2010-01-15
基金资助
福建省自然科学基金项目(编号：2008J0076)资助
Two novel mutations of FBN1 gene in the patients with MFS among Han population
Received date: 2009-07-09
Revised date: 2009-10-12
Online published: 2010-01-15
为调查马凡综合征(Marfan syndrome, MFS)患者的原纤维蛋白-1(Fibrillin-1, FBN1)基因突变情况, 应用聚合酶链反应(PCR)和变性高效液相色谱法(Denaturing high-performance liquid chromatography, DHPLC)对MFS患者的FBN1基因进行突变筛查, 对DHPLC初筛异常的DNA片段进行测序分析。结果在两个MFS家系中发现FBN1基因两种新的突变: 一种为复合突变包含第55号外显子的缺失突变c.6862_6871delGGCTGTGTAG (p.Gly2288MetfsX109)、同义突变c.6861A>G和内含子的突变c.[6871+1_6871+11delGTAAGAGGATC; 6871+34dupCATCAGAAGTGACAGTGGACA]; 另一种为第20号外显子的错义突变c.2462G>A(p.Cys821Tyr)。研究表明, FBN1基因的缺失突变c.[6862_6871delGGCTGTGTAG; 6871+1_6871+11delGTAAGAGGATC] (p.Gly2288MetfsX109)和错义突变c.2462G>A(p.Cys821Tyr)可能分别是这两个家系患者的致病原因。
陈清泉，伍严安，黄肖利，陈同，黄毅，陈发林，陈发文 . 汉族马凡综合征(MFS)患者FBN1基因两种新发突变分析[J]. 遗传, 2010 , 32(1) : 49 -53 . DOI: 10.3724/SP.J.1005.2010.00049
To detect the mutations of fibrillin-1 (FBN1) gene in the patients with Marfan syndrome (MFS), polymerase chain reaction (PCR) and denaturing high-performance liquid chromatography (DHPLC) were conducted to screen for the mutations in FBN1 gene. Sequence analyses were carried out when the DNA amplification fragments of the DHPLC elution profiles showed difference from the corresponding normal elution profile. Two novel mutations were detected in two families with MFS, respectively. One was a multiplex mutation in exon 55 containing a deletion mutation c.6862_6871delGGCTGTGTAG (p.Gly2288MetfsX109), a synonymous mutation (c.6861A>G) and an intronic mutation c.[6871+1_6871+11delGTAAGAGGATC; 6871+34dupCATCAGAAGTGACAGTGGACA], and the other was a missense mutation in exon 20 c.2462G>A (p.Cys821Tyr). The results indicated that the deletion mutation c.[6862_6871delGGCTGT GTAG; 6871+1_6871+11delGTAAGAGGATC] (p.Gly2288MetfsX109) and the missense mutation c.2462G>A (p.Cys821Tyr) of FBN1 gene may cause the two family patients with MFS respectively.
Key words： Marfan syndrome; fibrillin-1; gene; mutation; high-performance liquid chromatography
[1] Dietz HC, Cutting GR, Pyeritz RE, Masten CL, Sakai LY, Corson GM, Puffenberqer EG, Hamosh A, Nanthakumar EJ, Curristin SM. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 1991, 352(6333): 337–339.
[2] De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pveritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet, 1996, 62(4): 417–426.
[3] Collod-Beroud G, Le Bourdelles S, Ades L, Ala-kokko L, Booms P, Boxer M, Child A, Comeqlio P, De Paepe A, Hvland JC, Holman K, Kaitila I, Loeys B, Matyas G, Nuvtinck L, Peltonen L, Rantamanki T, Robinson P, Steinmann B, Junien C, Beroud C, Boileau C. Update of the UMD-FBN1mutation database and creation of an FBN1 polymorphism database. Hum Mutat, 2003, 22(3): 199–208.
[4] Robinson PN, Godfrey M. The molecular genetic of Mar-fan syndrome and related microfibrillopathies. J Med Genet, 2000, 37(1): 9–25.
[5] Robinson PN, Booms P, Katzke S, Ladewiq M, Neumann L, Palz M, Preqla R, Tieche E, Rosenberq T. Mutation of FBN1 and genotype correlations in Marfan syndrome and related fi-brillinopathies. Hum Mutat, 2002, 20(3): 153–161.
[6] Korkko J, Kaitila I, Lonnqvist L, Peltonen L, Ala-Kokko L. Sensitivity of conformation sensitive gelelectrophoresis in detecting mutations in Marfan syndrome and related con-ditions. J Med Genet, 2002, 39(1): 34–41.
[7] Nijbroek G, Sood S, McIntosh I, Francomano CA, Bull E, Pereira L, Ramirez F, Pyeritz RE, Dietz HC. Fifteen novel FBN1 mutation causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet, 1995, 57(1): 8–21.
[8] 伍严安, 陈喜军, 黄肖利, 陈同, 陈发文, 陈发林, 黄毅. Marfan综合征FBN1基因新的剪接位点的置换突变. 福建医科大学学报, 2007, 41(2): 156–158.
[9] Matyas G, De Paepe A, Halliday D, Boileau C, Pals G, Steinmann B. Evaluation and application of denaturing HPLC for mutations detection in Marfan syndrome: iden-tification of 20 novel mutation and two novel polymor-phisms in the FBN1 gene. Hum Mutat, 2002, 19(4): 443–456.
[10] Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kaiii T, Jondeau G, Ohta T, Kishino T, Furukawa Y,Nakamura Y, Niikawa N, Boileau C, Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet, 2004, 36(8): 855–860.
[11] Singh KK, Rommel K, Mishra A, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys–Dietz syndrome. Hum Mutat, 2006, 27(8): 770–777.
[12] Boileau C, Jondeau G, Mizuguchi T, Matsumoto N. Mo-lecular genetics of Marfan syndrome. Curr Opin Cardiol, 2005, 20(3): 194–200.
[13] Dietz HC, McIntosh I, Sakai LY, Corson GM, Chalberq SC, Pveritz RE, Francomano CA. Four novel FBN1 muta-tions: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics, 1993, 17(2): 468–475.
[14] Pereira L, Lee SY, Gayraud B, Andrikopoukos K, Shapiro SD, Bunton T, Bierv NJ, Dietz HC, Sakai LY, Ramirez F. Pathogenetic sequence for aneurysm revealed in mice un-derexpressing fibrillin-1. Proc Natl Acad Sci USA, 1999, 96(7): 3819–3823.
[15] Reinhardt DP, Ono RN, Notbohm H, Muller PK, Bachin-qer HP, Sakai LY. Mutation in calcimu-binding epidermal growth factor modules render fibrillin-1 susceptible to proteolysis. A potential disease-causing mechanism in Marfan syndrome. J Biol Chem, 2000, 275(16): 12339–12345.
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:
